- Home
- SLP
as of 02-27-2026 3:54pm EST
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | RESEARCH TRIANGLE PARK |
| Market Cap: | 293.5M | IPO Year: | 1996 |
| Target Price: | $25.00 | AVG Volume (30 days): | 387.5K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | quarterly |
| EPS: | 0.03 | EPS Growth: | -757.14 |
| 52 Week Low/High: | $11.16 - $36.43 | Next Earning Date: | 04-07-2026 |
| Revenue: | $59,577,000 | Revenue Growth: | 10.52% |
| Revenue Growth (this year): | 2.64% | Revenue Growth (next year): | 6.01% |
| P/E Ratio: | 404.00 | Index: | N/A |
| Free Cash Flow: | 17.4M | FCF Growth: | +104.83% |
AI-Powered SLP Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare SLP vs Leading Stocks
See how SLP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SLP Simulations Plus Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.